Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-21 Purchase |
2022-03-22 7:28 pm |
Design Therapeutics Inc. | DSGN | William Arsani Director |
25,000 | $18.99 | $474,680 | 6,047,629 (Indirect) |
View |
| 2022-03-18 Sale |
2022-03-22 7:26 pm |
Design Therapeutics Inc. | DSGN | Xu Stella Director |
590,880 | $19.07 | $11,266,197 | 4,139,950 (Indirect) |
View |
| 2021-08-31 Purchase |
2021-09-02 5:06 pm |
Design Therapeutics Inc. | DSGN | William Arsani Director |
40,000 | $15.45 | $618,000 | 6,022,629 (Indirect) |
View |
| 2021-03-30 Purchase |
2021-04-01 6:35 pm |
Design Therapeutics Inc. | DSGN | Jeffries Sean Chief Operating Officer |
3,050 | $20 | $61,000 | 3,050 (Indirect) |
View |
| 2021-03-30 Purchase |
2021-04-01 6:23 pm |
Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner |
250,000 | $20 | $5,000,000 | 5,626,476 (Direct) |
View |
| 2021-03-30 Purchase |
2021-04-01 6:19 pm |
Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner |
10,000 | $20 | $200,000 | 4,730,830 (Indirect) |
View |
| 2021-03-30 Purchase |
2021-04-01 6:18 pm |
Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner |
250,000 | $20 | $5,000,000 | 5,626,476 (Indirect) |
View |
| 2021-03-30 Purchase |
2021-04-01 6:17 pm |
Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director |
5,000 | $20 | $100,000 | 97,024 (Direct) |
View |
| 2021-03-30 Purchase |
2021-04-01 6:16 pm |
Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson |
25,000 | $20 | $500,000 | 154,923 (Indirect Direct) |
View |
| 2021-03-30 Purchase |
2021-04-01 6:14 pm |
Design Therapeutics Inc. | DSGN | Thacker Justin Vice President, Finance |
17,500 | $20 | $350,000 | 17,500 (Direct) |
View |
| 2021-03-30 Purchase |
2021-04-01 6:12 pm |
Design Therapeutics Inc. | DSGN | William Arsani Director |
700,000 | $20 | $14,000,000 | 2,732,501 (Indirect) |
View |
| 2021-03-30 Purchase |
2021-04-01 4:15 pm |
Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
750,000 | $20 | $15,000,000 | 5,114,844 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-15 Option Award |
2022-06-16 5:17 pm |
N/A 2032-06-14 |
Design Therapeutics Inc. | DSGN | Xu Stella Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 5:16 pm |
N/A 2032-06-14 |
Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 5:10 pm |
N/A 2032-06-14 |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 5:08 pm |
N/A 2032-06-14 |
Design Therapeutics Inc. | DSGN | William Arsani Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 5:07 pm |
N/A 2032-06-14 |
Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 5:06 pm |
N/A 2032-06-14 |
Design Therapeutics Inc. | DSGN | Prasad Deepa Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 5:05 pm |
N/A 2032-06-14 |
Design Therapeutics Inc. | DSGN | Berger Heather A. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-03-16 Other |
2022-03-18 5:37 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Prasad Deepa Director |
11,806 | $0 | 23,612 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 7:51 pm |
N/A 2032-01-31 |
Design Therapeutics Inc. | DSGN | Jeffries Sean Chief Operating Officer |
350,000 | $0 | 350,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 7:50 pm |
N/A 2032-01-31 |
Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson |
475,000 | $0 | 475,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 7:50 pm |
N/A 2032-01-31 |
Design Therapeutics Inc. | DSGN | Siffert Joao MD President and CEO |
475,000 | $0 | 475,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 7:49 pm |
N/A 2032-01-31 |
Design Therapeutics Inc. | DSGN | Burgess Julie Chief Accounting Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-04 4:53 pm |
N/A 2031-09-30 |
Design Therapeutics Inc. | DSGN | Burgess Julie Chief Accounting Officer |
135,000 | $0 | 135,000 (Direct) |
View |
Ownership |
2021-08-17 7:21 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Giangiulio Dawn Principal Accounting Officer |
0 | $0 | 44,308 (Direct) |
View |
| 2021-06-15 Option Award |
2021-06-16 5:21 pm |
N/A 2031-06-14 |
Design Therapeutics Inc. | DSGN | Prasad Deepa Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2021-06-16 5:20 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Prasad Deepa Director |
0 | $0 | 1,817,273 (Indirect) |
View |
| 2021-06-15 Option Award |
2021-06-16 5:17 pm |
N/A 2031-06-14 |
Design Therapeutics Inc. | DSGN | Behanna Heather Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:25 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Quan Venture Fund II L.P. 10% Owner |
12,415,784 | $0 | 4,720,830 (Direct) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:23 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner |
14,140,132 | $0 | 5,626,476 (Direct) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:19 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner |
12,415,784 | $0 | 4,730,830 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:18 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner |
14,140,132 | $0 | 5,626,476 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:16 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson |
275,948 | $0 | 154,923 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-04-01 6:12 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | William Arsani Director |
5,345,479 | $0 | 2,732,501 (Indirect) |
View |
| 2021-03-30 Conversion |
2021-04-01 4:15 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
8,729,688 | $0 | 5,114,844 (Indirect) |
View |
Ownership(A) |
2021-03-30 5:44 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner |
0 | $0 | 5,376,476 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 6:31 pm |
N/A 2031-03-24 |
Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 5:56 pm |
N/A 2031-03-24 |
Design Therapeutics Inc. | DSGN | William Arsani Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 5:55 pm |
N/A 2031-03-24 |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 5:54 pm |
N/A 2031-03-24 |
Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 5:52 pm |
N/A 2031-03-24 |
Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2021-03-25 9:17 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP 10% Owner |
0 | $0 | 5,376,476 (Direct) |
View |
Ownership |
2021-03-25 9:15 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Xu Stella Quan Venture Fund II L.P. Director 10% Owner |
0 | $0 | 4,720,830 (Indirect) |
View |